(Presolicitation Notice) Intent to Sole Source - Biol Specimens for Lenacapavir PEP
Inactive on SAM.gov — responses were due 17 Sep 2026 · No Set aside used · Centers for Disease Control and Prevention (CDC), HHS · Atlanta, GA · NAICS 621511 · Solicitation PR97866
Following NAICS 621511? Get new solicitations in it by email as they post — no account needed.
SAM.gov marked this notice inactive — responses were due 17 September 2026.
No award notice on SAM.gov yet. Not every award is posted there, so this does not mean it went unawarded.
Email me when the award is announced. One email, when SAM.gov posts the award notice. Not every award is posted there; if none appears within six months we'll tell you and stop. No account needed.
Likely sole source (FedSift estimate from the notice text) — confirm on SAM.gov before investing in a bid
Get new NAICS 621511 solicitations by email
This one has closed. We'll email you when new NAICS 621511 (Medical Laboratories) solicitations post — the first email lists what is open right now, then at most once a week, only when something new posts. No account needed; unsubscribe in a click.
Description
The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Emory University for the procurement and delivery of biological specimens from persons receiving weekly oral lenacapavir. Emory maintains established HIV clinical-research infrastructure, including HIV prevention and treatment clinical-research capabilities, and has documented prior experience performing CDC-supported clinical studies involving extensive biological specimen collection and pharmacokinetic-related procedures. Emory also has prior CDC DHP contract performance and documented experience with the collection, processing, handling, and transfer of biological specimens required for CDC-supported research. This established experience provides continuity with CDC DHP laboratory methods and specimen-handling procedures and reduces technical risk associated with protocol implementation, specimen-processing method transfer, study start-up, and preservation of specimen integrity. In addition, Emory s Atlanta-area location permits timely and predictable monthly transport of specimens to the CDC DHP Laboratory Branch. This proximity reduces cold-chain transportation time, shipping variability, weather-related exposure, and other risks that could adversely affect specimen integrity and comparability. This contract action is for services for which the Government intends to solicit and negotiate with only one source under the authority of RFO FAR 12.201-1 simplified procedures pursuant to 41 U.S.C. 1901, and is justified under 41 U.S.C. 3304(a)(1). See note below. This notice of intent is not a request for competitive quotations; however, all quotations/responses received within 15 of days of the issuance of this notice shall be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist at xmr1@cdc.gov, by the closing date of this posting.
Go deeper on this solicitation
FedSift reads the full solicitation package — every attachment — and pre-extracts the compliance matrix, evaluation factors, key risks, win themes and deal-breakers, each with a verbatim quote and the exact PDF page it came from. It scores the opportunity against your company profile, tells you whether to bid as prime or sub, and ranks teaming partners who could close your gaps.
Source: this notice on SAM.gov. FedSift republishes public federal procurement data and is not affiliated with the U.S. Government. Always confirm dates and requirements against SAM.gov before responding.
